Mario Gabelli Novartis Ag Transaction History

Gamco Investors, Inc. Et Al

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $215,015 - $243,224	-2,684 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $213,914 - $236,540	2,684 New	2,684 $235,000
Q3 2020 Nov 06, 2020	SELL	$82.14 - $91.0 $1.08 Million - $1.19 Million	-13,095 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $70,670 - $99,010	1,000 Added 8.27%	13,095 $1.08 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $33,740 - $38,148	-400 Reduced 3.2%	12,095 $1.15 Million
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $56,456 - $62,211	-660 Reduced 5.02%	12,495 $1.09 Million
Q2 2019 Aug 02, 2019	BUY	$75.4 - $92.8 $757,770 - $932,640	10,050 Added 323.67%	13,155 $1.2 Million
Q1 2019 May 02, 2019	BUY	$75.32 - $86.15 $233,868 - $267,495	3,105 New	3,105 $299,000
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $178,177 - $201,373	-2,745 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $191,674 - $205,746	-2,650 Reduced 49.12%	2,745 $230,000
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $399,985 - $416,871	5,395	5,395 $463,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.